Platelet-rich plasma for stubborn corneal surface wounds
Part of Eyes & vision clinical trials.
This trial studies injecting your own platelet-rich plasma into the eye to help a persistent corneal surface defect heal. It may help if you have a recurring or nerve-related corneal ulcer, but it’s not for certain ulcer types or active eye infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a persistent (not healing) corneal surface defect.
- You have at least one qualifying problem: recurrent corneal epithelial defects, neurotrophic corneal ulcers, or nerve-related corneal damage from another condition (like diabetes, herpes infections, nerve problems, burns, injury, surgery, chronic dry eye, or some nerve diseases).
- Your ulcer is not a peripheral ulcerative keratitis or Mooren’s ulcer.
- You do not currently have an active infectious keratitis (an active eye infection) or an active infected ulcer.
- You must be available for the trial’s treatment and follow-up visits as required by the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether your own platelet-rich plasma can help heal a fragile, slow-to-recover cornea caused by reduced corneal feeling (nerve damage). It may help reduce corneal erosion and improve corneal surface healing.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This trial tests whether an injection of a special concentrate from your own blood (platelet-rich plasma, or PRP) can help calm severe dry eye disease. It’s meant for people whose dry eye has not improved with other treatments.
This trial tests whether a treatment made from your own blood (platelet-rich plasma) can help heal deep skin ulcers (Grade III) that have been present for more than two weeks. It may be a good option if you have a normal platelet count and are not in palliative care.
This study tests a treatment made from your own blood that is applied to a wound that has not healed after standard care. The goal is to see if this gel can help the wound close and heal better.
This study tests whether a treatment made from your own blood (platelet-rich plasma or platelet-rich fibrin) can help heal chronic skin ulcers better than standard care. If you have a non-healing ulcer that fits the size and duration criteria, and you are generally healthy, you may be able to participate.
Hear when a new Persistent Epithelial Defect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.